Fate Therapeutics Stock Technical Analysis
| FATE Stock | USD 1.25 0.05 4.17% |
As of the 17th of February 2026, Fate Therapeutics shows the Downside Deviation of 4.6, coefficient of variation of 1484.84, and Mean Deviation of 3.69. Fate Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Fate Therapeutics variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if Fate Therapeutics is priced favorably, providing market reflects its regular price of 1.25 per share. Given that Fate Therapeutics is a hitting penny stock territory we advise to closely look at its total risk alpha.
Fate Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Fate, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to FateFate Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Fate Therapeutics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 4.94 | Buy | 12 | Odds |
Most Fate analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Fate stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Fate Therapeutics, talking to its executives and customers, or listening to Fate conference calls.
Will Biotechnology sector continue expanding? Could Fate diversify its offerings? Factors like these will boost the valuation of Fate Therapeutics. Market participants price Fate higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Fate Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.33) | Revenue Per Share | Quarterly Revenue Growth (0.43) | Return On Assets | Return On Equity |
The market value of Fate Therapeutics is measured differently than its book value, which is the value of Fate that is recorded on the company's balance sheet. Investors also form their own opinion of Fate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Fate Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Fate Therapeutics' market value can be influenced by many factors that don't directly affect Fate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fate Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Fate Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Fate Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fate Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fate Therapeutics.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Fate Therapeutics on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Fate Therapeutics or generate 0.0% return on investment in Fate Therapeutics over 90 days. Fate Therapeutics is related to or competes with Nkarta, Alector, Vor Biopharma, Cassava Sciences, Prelude Therapeutics, Inovio Pharmaceuticals, and PepGen. Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for ca... More
Fate Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fate Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fate Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.6 | |||
| Information Ratio | 0.0524 | |||
| Maximum Drawdown | 22.03 | |||
| Value At Risk | (7.56) | |||
| Potential Upside | 8.0 |
Fate Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fate Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fate Therapeutics' standard deviation. In reality, there are many statistical measures that can use Fate Therapeutics historical prices to predict the future Fate Therapeutics' volatility.| Risk Adjusted Performance | 0.0626 | |||
| Jensen Alpha | 0.1878 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.053 | |||
| Treynor Ratio | 0.1568 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fate Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Fate Therapeutics February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0626 | |||
| Market Risk Adjusted Performance | 0.1668 | |||
| Mean Deviation | 3.69 | |||
| Semi Deviation | 4.02 | |||
| Downside Deviation | 4.6 | |||
| Coefficient Of Variation | 1484.84 | |||
| Standard Deviation | 4.66 | |||
| Variance | 21.75 | |||
| Information Ratio | 0.0524 | |||
| Jensen Alpha | 0.1878 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.053 | |||
| Treynor Ratio | 0.1568 | |||
| Maximum Drawdown | 22.03 | |||
| Value At Risk | (7.56) | |||
| Potential Upside | 8.0 | |||
| Downside Variance | 21.2 | |||
| Semi Variance | 16.17 | |||
| Expected Short fall | (4.51) | |||
| Skewness | 0.2177 | |||
| Kurtosis | 0.0756 |
Fate Therapeutics Backtested Returns
Fate Therapeutics appears to be very risky, given 3 months investment horizon. Fate Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0851, which denotes the company had a 0.0851 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Fate Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Fate Therapeutics' Mean Deviation of 3.69, downside deviation of 4.6, and Coefficient Of Variation of 1484.84 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Fate Therapeutics holds a performance score of 6. The firm shows a Beta (market volatility) of 1.94, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Fate Therapeutics will likely underperform. Please check Fate Therapeutics' accumulation distribution, day typical price, as well as the relationship between the semi variance and maximum drawdown , to make a quick decision on whether Fate Therapeutics' price patterns will revert.
Auto-correlation | 0.06 |
Virtually no predictability
Fate Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between Fate Therapeutics time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fate Therapeutics price movement. The serial correlation of 0.06 indicates that barely 6.0% of current Fate Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | -0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Fate Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Fate Therapeutics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Fate Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Fate Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Fate Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Fate Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Fate Therapeutics price pattern first instead of the macroeconomic environment surrounding Fate Therapeutics. By analyzing Fate Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Fate Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Fate Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 (projected) | Interest Debt Per Share | 1.05 | 0.75 | 0.68 | Revenue Per Share | 0.65 | 0.12 | 0.11 |
Fate Therapeutics February 17, 2026 Technical Indicators
Most technical analysis of Fate help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Fate from various momentum indicators to cycle indicators. When you analyze Fate charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0626 | |||
| Market Risk Adjusted Performance | 0.1668 | |||
| Mean Deviation | 3.69 | |||
| Semi Deviation | 4.02 | |||
| Downside Deviation | 4.6 | |||
| Coefficient Of Variation | 1484.84 | |||
| Standard Deviation | 4.66 | |||
| Variance | 21.75 | |||
| Information Ratio | 0.0524 | |||
| Jensen Alpha | 0.1878 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.053 | |||
| Treynor Ratio | 0.1568 | |||
| Maximum Drawdown | 22.03 | |||
| Value At Risk | (7.56) | |||
| Potential Upside | 8.0 | |||
| Downside Variance | 21.2 | |||
| Semi Variance | 16.17 | |||
| Expected Short fall | (4.51) | |||
| Skewness | 0.2177 | |||
| Kurtosis | 0.0756 |
Fate Therapeutics February 17, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Fate stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.09 | ||
| Daily Balance Of Power | 0.45 | ||
| Rate Of Daily Change | 1.04 | ||
| Day Median Price | 1.23 | ||
| Day Typical Price | 1.24 | ||
| Price Action Indicator | 0.04 | ||
| Market Facilitation Index | 0.11 |
Complementary Tools for Fate Stock analysis
When running Fate Therapeutics' price analysis, check to measure Fate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fate Therapeutics is operating at the current time. Most of Fate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fate Therapeutics' price. Additionally, you may evaluate how the addition of Fate Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |